Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RALPH BOCCIA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1881663284
CMS profile
175674
Location
BETHESDA, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$393,668.10

454 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Ownership and Investment Interests

CMS also publishes Ownership and Investment Interests as a separate dataset. This site does not currently mirror it, and no ownership figure is shown on this page. This provider appears in that dataset.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $33,544.17 39
E.R. Squibb & Sons, L.L.C. $28,068.54 15
Dova Pharmaceuticals $25,508.88 10
Coherus Biosciences Inc. $24,060.08 19
Janssen Biotech, Inc. $23,781.72 35
G1 Therapeutics, Inc. $22,411.42 14
Karyopharm Therapeutics Inc. $19,981.13 12
Incyte Corporation $19,455.44 21
Epizyme, Inc., $18,592.13 12
Celgene Corporation $17,755.93 18
GENZYME CORPORATION $16,156.64 18
PUMA BIOTECHNOLOGY, INC. $15,959.19 12
Rigel Pharmaceuticals, Inc. $15,224.40 10
Taiho Oncology, Inc. $12,628.78 12
BeiGene USA, Inc. $12,573.55 11
GlaxoSmithKline, LLC. $11,274.68 6
Daiichi Sankyo Inc. $10,283.49 12
Veracyte, Inc. $9,750.00 3
Pharmacosmos Therapeutics Inc. $8,649.42 5
Regeneron Healthcare Solutions, Inc. $7,626.53 8
Amgen Inc. $5,963.10 9
AbbVie Inc. $5,914.21 9
JAZZ PHARMACEUTICALS INC. $4,790.00 3
Blueprint Medicines Corporation $4,498.31 7
UCB SA $4,140.00 1
Genentech USA, Inc. $3,731.52 9
PFIZER INC. $2,446.81 4
Kite Pharma, Inc. $2,027.16 5
ADC Therapeutics America, Inc. $1,800.00 1
Bayer HealthCare Pharmaceuticals Inc. $1,107.04 7
Acceleron Pharma, Inc. $886.57 4
EMD Serono, Inc. $724.15 2
Novartis Pharmaceuticals Corporation $395.87 18
TG THERAPEUTICS, INC. $177.58 2
Merck Sharp & Dohme Corporation $167.81 10
Takeda Pharmaceuticals U.S.A., Inc. $167.27 7
Seagen Inc. $126.39 6
Pharmacyclics LLC, An AbbVie Company $111.76 4
Eisai Inc. $106.78 6
Genentech, Inc. $104.31 1
Myovant Sciences Inc. $103.20 5
Gilead Sciences, Inc. $103.11 4
Lilly USA, LLC $96.89 6
Global Blood Therapeutics, Inc. $95.89 4
Exelixis Inc. $94.30 5
Astellas Pharma US Inc $86.51 4
Sobi, Inc $85.41 1
Janssen Pharmaceuticals, Inc $41.64 3
Deciphera Pharmaceuticals Inc. $37.88 2
ARRAY BIOPHARMA INC $28.51 2
Boehringer Ingelheim Pharmaceuticals, Inc. $28.47 1
Clovis Oncology, Inc. $25.00 1
Aveo Pharmaceuticals, Inc. $24.58 1
EUSA Pharma (US) LLC $23.71 1
Acrotech Biopharma LLC $22.26 1
MorphoSys, US Inc. $20.30 1
Alexion Pharmaceuticals, Inc. $17.96 1
Stemline Therapeutics Inc. $17.60 1
Servier Pharmaceuticals LLC $15.93 1
Myriad Genetic Laboratories, Inc. $14.41 1
Emmaus Medical, Inc. $11.78 1

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

454 matching records · $393,668.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 454 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 454.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Eisai Inc. $20.5812/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818072683 CMS
MorphoSys, US Inc. $20.3012/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026854731037 CMS
Janssen Biotech, Inc. $1,350.0012/28/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788783261 CMS
Emmaus Medical, Inc. $11.7812/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026850483901 CMS
Janssen Biotech, Inc. $18.9012/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788783263 CMS
E.R. Squibb & Sons, L.L.C. $6,555.0012/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783606265 CMS
Seagen Inc. $19.9512/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832173881 CMS
Daiichi Sankyo Inc. $625.0012/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026836326377 CMS
Janssen Biotech, Inc. $1,350.0012/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788783259 CMS
PUMA BIOTECHNOLOGY, INC. $9.3212/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026834092041 CMS
PUMA BIOTECHNOLOGY, INC. $0.9212/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026834092049 CMS
Amgen Inc. $18.4012/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026826413493 CMS
Celgene Corporation $1,650.0012/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026853634457 CMS
Coherus Biosciences Inc. $6,750.0012/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026855104253 CMS
GENZYME CORPORATION $16.0012/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843504195 CMS
Dova Pharmaceuticals $4,235.0012/15/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849749641 CMS
Novartis Pharmaceuticals Corporation $21.4012/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026812612927 CMS
AstraZeneca Pharmaceuticals LP $1,370.0012/14/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829509387 CMS
G1 Therapeutics, Inc. $1,800.0012/14/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026840102229 CMS
Janssen Biotech, Inc. $14.0512/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788783271 CMS
Merck Sharp & Dohme Corporation $16.8112/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848598645 CMS
Acceleron Pharma, Inc. $20.6912/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843318371 CMS
Dova Pharmaceuticals $4,235.0012/13/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849749639 CMS
Dova Pharmaceuticals $31.1412/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849747673 CMS
Pharmacyclics LLC, An AbbVie Company $40.1812/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026781008435 CMS
Celgene Corporation $29.7312/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783719131 CMS
Dova Pharmaceuticals $30.1312/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849747671 CMS
Gilead Sciences, Inc. $46.6412/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848165483 CMS
AbbVie Inc. $15.0012/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026794097571 CMS
Rigel Pharmaceuticals, Inc. $119.4812/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026854329955 CMS
TG THERAPEUTICS, INC. $120.3012/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026844042551 CMS
Celgene Corporation $1,650.0012/09/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026853634461 CMS
E.R. Squibb & Sons, L.L.C. $6,210.0012/09/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783606261 CMS
GlaxoSmithKline, LLC. $21.8812/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026802534681 CMS
Celgene Corporation $600.0012/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026853634465 CMS
Celgene Corporation $1,650.0012/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026853634469 CMS
Daiichi Sankyo Inc. $625.0012/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026836325929 CMS
G1 Therapeutics, Inc. $1,800.0012/06/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026840102225 CMS
Genentech USA, Inc. $19.4512/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835964821 CMS
Coherus Biosciences Inc. $5.0012/04/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026855104257 CMS
Coherus Biosciences Inc. $63.8312/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026855104261 CMS
Coherus Biosciences Inc. $9.9912/04/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026855104281 CMS
Incyte Corporation $16.3812/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835520511 CMS
Coherus Biosciences Inc. $50.2712/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026855104265 CMS
Coherus Biosciences Inc. $172.5012/03/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026855104269 CMS
Coherus Biosciences Inc. $336.8112/03/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026855104273 CMS
Coherus Biosciences Inc. $15.9912/03/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026855104277 CMS
BeiGene USA, Inc. $1,950.0012/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026846696697 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.9512/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026819869177 CMS
Global Blood Therapeutics, Inc. $22.5711/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835338429 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $707,458.24 649
PY2020 $452,016.98 405
PY2021 $393,668.10 454
PY2022 $493,041.79 506
PY2023 $415,808.04 493
PY2024 $433,660.62 450
PY2025 $244,074.29 326

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
RALPH BOCCIA, NPI 1881663284. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1881663284.
APA 7
IndustryPayments. (2026). RALPH BOCCIA, NPI 1881663284 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1881663284
Bluebook
RALPH BOCCIA, NPI 1881663284, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1881663284.

Source: Centers for Medicare & Medicaid Services, Open Payments.